SCHEMBL9526560

SCHEMBL9526560

CNC(C)N(C(=O)c1sc(C)c(C)c1OC)C(C)NC

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 3/20 0.32
TP53 P04637 1/20 0.32
LMNA P02545 1/20 0.31
CISD2 Q8N5K1 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KDM4E B2RXH2 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9525428 0.85 KDM4E (0.33) ALDH1A1L3MBTL1HPGDTP53KDM4E
SCHEMBL9365819 0.83 GAA (0.32)
SCHEMBL9368107 0.72 ALDH1A1 (0.46) ALDH1A1HPGDTP53LMNACISD2
SCHEMBL9367169 0.70 ALDH1A1 (0.40) ALDH1A1L3MBTL1HPGDTP53CISD2
SCHEMBL9366088 0.70 KDM4E (0.31) ALDH1A1HPGDTP53KDM4E
SCHEMBL3055938 0.69 ALDH1A1 (0.33) ALDH1A1L3MBTL1HPGDTP53LMNA
Dimethylamine SCHEMBL9526570 0.67 CHRM4 (0.44) ALDH1A1L3MBTL1HPGDLMNACISD2
SCHEMBL9365797 0.65 CISD2 (0.31) ALDH1A1L3MBTL1CISD2KDM4E
SCHEMBL9526562 0.64 CYP2D6 (0.45) ALDH1A1LMNACYP1A2KDM4E
SCHEMBL9365766 0.63 ALDH1A1 (0.31) ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0297697-B1 Thiophene-2-carboxamide derivatives and their pharmaceutical use LILLY SA (ES) 1993-12-29 EP disclosed
US-4904686-A 3-ALKOXYTHIOPHENE-2-CARBOXAMIDES; CENTRAL NERVOUS SYSTEM DISORDERS LILLY INDUSTRIES LIMITED (GB) 1990-02-27 US disclosed
EP-0297697-A1 Thiophene-2-carboxamide derivatives and their pharmaceutical use LILLY S.A. (ES) 1989-01-04 EP disclosed